May 19, 2017   Sweden
Aktiespararna.se: Intervju med vd Ulf Hannelius
Caroline Berglund från Aktiespararna intervjuar vd Ulf Hannelius och talar om diabetesvaccinet Diamyd och framtiden.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS